A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis...

Area of Science:

• Tuberculosis research
• Clinical trial methodology
• Pharmacological treatment

Background:

• Pulmonary tuberculosis (TB) treatment efficacy endpoints require standardized assessment.
• Existing methods may introduce bias in evaluating treatment outcomes.
• Novel approaches are needed to accurately determine the success of TB regimens.

Purpose of the Study:

• To describe and evaluate a standardized method, possible poor treatment response (PPTR), for ascertaining efficacy endpoints in a TB treatment trial.
• To assess if the PPTR process minimizes bias in efficacy endpoint assessment.
• To determine if the PPTR process yields relevant data for all participants' outcomes.

Main Methods:

• A PPTR event was defined by prespecified triggers requiring standardized evaluation.
• The evaluation process included microbiological assessment using multiple sputum samples.
• Study S31/A5349 compared two 4-month rifapentine-based regimens against a standard 6-month TB treatment.

Main Results:

• Out of 2,343 participants, 19.4% experienced 534 PPTR events; 76.6% were microbiological.
• 92.4% of participants with unfavorable TB outcomes had at least one PPTR event.
• 75% of participants with unfavorable outcomes showed microbiological confirmation of treatment failure.

Conclusions:

• Standardized methodologies like the PPTR approach can facilitate unbiased efficacy outcome determinations.
• The PPTR method improves discrimination between regimen-related and unrelated outcomes.
• This approach enhances the capability for pooled analyses across contemporary TB trials.